ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA
Launched by VITAA MEDICAL SOLUTIONS · Aug 4, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The ViTAA Registry study is looking at patients with abdominal aortic aneurysms, which are bulges in the aorta that can be serious if not treated. This study aims to collect important information about these patients both before and after a specific type of surgery called endovascular repair. This surgery uses a minimally invasive approach to fix the aneurysm. The researchers want to see how effective this treatment is and to monitor patients over time using a special technology developed by ViTAA to map the aorta.
To participate in this study, you need to be at least 18 years old and have an aortic aneurysm that is 45 mm or larger. However, there are some health conditions that would exclude you from the study, such as certain heart issues or major diseases that affect your connective tissues. If you join the study, you can expect to undergo regular check-ups and imaging tests to track your condition and the effectiveness of the treatment. This study is currently recruiting participants, so if you or someone you know fits the criteria, it might be an opportunity to contribute to important research while receiving careful monitoring.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient is aged 18 years or over
- • 2. Infrarenal Aortic Aneurysm ≥ 45 mm in diameter.
- • 3. Patient meets on-IFU criteria for endovascular reconstruction
- Exclusion Criteria:
- • 1. Patient has a known or clinically suspected major connective tissue disorder, autoimmune disorder, vasculitis, or aortic dissection.
- • 2. Patient has renal failure (defined as dialysis dependent or serum creatinine ≥2.0mg/dL or 175umol/L
- • 3. Patients with previous aortic reconstruction in the involved segment.
- • 4. Patients receiving oral or parenteral corticosteroid therapy for other unrelated disease. (Excludes inhaled corticosteroids).
- • 5. Patient has a sensitivity to contrast imaging agents.
- • 6. Patient has aortic dissection.
- • 7. Patient has atrial fibrillation.
- • 8. Patient has arrhythmia.
About Vitaa Medical Solutions
Vitaa Medical Solutions is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on enhancing patient outcomes, Vitaa Medical Solutions specializes in designing and executing clinical trials that explore cutting-edge medical technologies and therapeutic interventions. Committed to rigorous scientific standards and regulatory compliance, the organization collaborates with healthcare professionals, researchers, and institutions to ensure the effective translation of research findings into clinical practice. By prioritizing patient safety and ethical considerations, Vitaa Medical Solutions aims to contribute significantly to the evolution of medical treatments and improve the quality of care across diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Boston, Massachusetts, United States
Chapel Hill, North Carolina, United States
Calgary, Alberta, Canada
Toronto, Ontario, Canada
Montreal, Quebec, Canada
Montréal, Quebec, Canada
Patients applied
Trial Officials
Mark Farber
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials